EXAS - Exact Sciences Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
Madison,
United States
Type: Equity
EXAS price evolution
EXAS
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $605.38 | $594.61 | $604.36 | $421.37 |
| Short term investments | $172.27 | $139.79 | $171.35 | $277.28 |
| Net receivables | $203.62 | $199.4 | $178.32 | $183.37 |
| Inventory | $127.47 | $132.84 | $130.77 | $124.09 |
| Total current assets | $1194.37 | $1148.19 | $1173.93 | $1091.38 |
| Long term investments | ||||
| Property, plant & equipment | $842.06 | $842.08 | $835.29 | $841.36 |
| Goodwill & intangible assets | $4257.52 | $4279.82 | $4256.81 | $4279.72 |
| Total noncurrent assets | $5276.97 | $5272.64 | $5181.64 | $5212.94 |
| Total investments | $172.27 | $139.79 | $171.35 | $277.28 |
| Total assets | $6471.33 | $6420.83 | $6355.56 | $6304.33 |
| Current liabilities | ||||
| Accounts payable | $78.82 | $73.56 | $75.08 | $86.71 |
| Deferred revenue | ||||
| Short long term debt | $79.38 | $80.39 | $79.87 | $30.01 |
| Total current liabilities | $514.7 | $476.51 | $488.06 | $367.35 |
| Long term debt | $2475.35 | $2481.32 | $2480.07 | $2534.89 |
| Total noncurrent liabilities | $2811.33 | $2823.09 | $2810.88 | $2879.27 |
| Total debt | $2554.72 | $2561.71 | $2559.94 | $2564.9 |
| Total liabilities | $3326.03 | $3299.6 | $3298.94 | $3246.62 |
| Shareholders' equity | ||||
| Retained earnings | -$3469.18 | -$3419.41 | -$3420.2 | -$3339.18 |
| Other shareholder equity | $1.43 | -$1.53 | -$0.72 | -$1.72 |
| Total shareholder equity | $3145.3 | $3121.23 | $3056.62 | $3057.71 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $605.38 | $178.17 | $315.47 | $1491.29 |
| Short term investments | $172.27 | $389.56 | $715 | $348.7 |
| Net receivables | $203.62 | $158.04 | $216.65 | $233.19 |
| Inventory | $127.47 | $118.26 | $104.99 | $92.27 |
| Total current assets | $1194.37 | $982.26 | $1426.24 | $2198.59 |
| Long term investments | $29.1 | |||
| Property, plant & equipment | $842.06 | $861.96 | $754.47 | $576.63 |
| Goodwill & intangible assets | $4257.52 | $4302.28 | $4429.58 | $2086.1 |
| Total noncurrent assets | $5276.97 | $5244.62 | $5258.65 | $2726.5 |
| Total investments | $172.27 | $389.56 | $715 | $348.7 |
| Total assets | $6471.33 | $6226.87 | $6684.88 | $4925.09 |
| Current liabilities | ||||
| Accounts payable | $78.82 | $74.92 | $67.83 | $35.71 |
| Deferred revenue | ||||
| Short long term debt | $79.38 | $28.37 | $19.71 | $268.27 |
| Total current liabilities | $514.7 | $412.75 | $517.07 | $575.84 |
| Long term debt | $2475.35 | $2243.51 | $2362.4 | $1464.18 |
| Total noncurrent liabilities | $2811.33 | $2770.96 | $2780.18 | $1525.76 |
| Total debt | $2554.72 | $2446.87 | $2382.11 | $1732.44 |
| Total liabilities | $3326.03 | $3183.71 | $3297.25 | $2101.6 |
| Shareholders' equity | ||||
| Retained earnings | -$3469.18 | -$3265.03 | -$2641.52 | -$1968.29 |
| Other shareholder equity | $1.43 | $0.05 | -$1.44 | $0.53 |
| Total shareholder equity | $3145.3 | $3043.16 | $3387.64 | $2823.49 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $646.88 | $628.34 | $622.09 | $602.45 |
| Cost of revenue | $171.87 | $168.53 | $156.99 | $156.87 |
| Gross Profit | $475.02 | $459.81 | $465.1 | $445.58 |
| Operating activities | ||||
| Research & development | $114.92 | $111.45 | $104.09 | $95.42 |
| Selling, general & administrative | $411.03 | $390.55 | $414.45 | $404.26 |
| Total operating expenses | $542.86 | $452.96 | $542.03 | $522.67 |
| Operating income | -$67.84 | $6.85 | -$76.93 | -$77.09 |
| Income from continuing operations | ||||
| EBIT | -$42.51 | $8.91 | -$72.1 | -$76.6 |
| Income tax expense | -$0.61 | $0.25 | $1.11 | $1.66 |
| Interest expense | $7.87 | $7.87 | $7.82 | -$4.11 |
| Net income | ||||
| Net income | -$49.77 | $0.79 | -$81.03 | -$74.15 |
| Income (for common shares) | -$49.77 | $0.79 | -$81.03 | -$74.15 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2499.77 | $2084.28 | $1767.09 | $1491.39 |
| Cost of revenue | $654.25 | $574.39 | $458.76 | $354.32 |
| Gross Profit | $1845.52 | $1509.88 | $1308.33 | $1137.07 |
| Operating activities | ||||
| Research & development | $425.88 | $393.42 | $385.65 | $554.05 |
| Selling, general & administrative | $1620.29 | $1583.32 | $1663.15 | $1071.63 |
| Total operating expenses | $2060.53 | $2103.4 | $2164.01 | $1905.09 |
| Operating income | -$215.01 | -$593.51 | -$855.68 | -$768.02 |
| Income from continuing operations | ||||
| EBIT | -$182.3 | -$612.94 | -$823.9 | -$761.12 |
| Income tax expense | $2.4 | -$9.06 | -$246.88 | -$8.57 |
| Interest expense | $19.45 | $19.63 | $18.61 | $95.98 |
| Net income | ||||
| Net income | -$204.15 | -$623.51 | -$595.63 | -$848.53 |
| Income (for common shares) | -$204.15 | -$623.51 | -$595.63 | -$848.53 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$49.77 | $0.79 | -$81.03 | -$74.15 |
| Operating activities | ||||
| Depreciation | $61.15 | $59.4 | $57.41 | $56.55 |
| Business acquisitions & disposals | -$12.21 | -$50 | ||
| Stock-based compensation | $58.58 | $61.87 | $61.73 | $49.14 |
| Total cash flows from operations | $69.55 | $24.36 | $100.42 | -$38.22 |
| Investing activities | ||||
| Capital expenditures | -$34.92 | -$25.19 | -$34.72 | -$29.36 |
| Investments | -$20.14 | $32.67 | $101.69 | $112.3 |
| Total cash flows from investing | -$66.77 | -$32.97 | $66.47 | $82.94 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $12.3 | $1.08 | $17.2 | $0.96 |
| Net borrowings | $137.98 | |||
| Total cash flows from financing | $10.04 | $0.09 | $16.04 | $133.6 |
| Effect of exchange rate | $1.95 | -$1.24 | $0.06 | $0.55 |
| Change in cash and equivalents | $14.77 | -$9.75 | $183 | $178.87 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$204.15 | -$623.51 | -$595.63 | -$848.53 |
| Operating activities | ||||
| Depreciation | $234.5 | $226.2 | $206.17 | $179.08 |
| Business acquisitions & disposals | -$52.91 | -$57.51 | -$575.85 | -$434.03 |
| Stock-based compensation | $231.31 | $206.82 | $334.02 | $152.91 |
| Total cash flows from operations | $156.12 | -$223.56 | -$102.24 | $136.48 |
| Investing activities | ||||
| Capital expenditures | -$124.19 | -$189.46 | -$135.77 | -$64.35 |
| Investments | $226.53 | $321.59 | -$369.73 | -$203.28 |
| Total cash flows from investing | $49.68 | $74.07 | -$1082.09 | -$702.04 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $31.54 | $32.02 | $37.51 | $907.13 |
| Net borrowings | $137.98 | $50 | -$23.75 | $975.49 |
| Total cash flows from financing | $159.77 | $76.48 | $8.47 | $1879.62 |
| Effect of exchange rate | $1.32 | $0.03 | $0.02 | |
| Change in cash and equivalents | $366.88 | -$72.98 | -$1175.83 | $1314.07 |
News
Fundamentals
| Market cap | $10.66B |
|---|---|
| Enterprise value | $12.61B |
| Shares outstanding | 181.36M |
| Revenue | $2.50B |
|---|---|
| EBITDA | $52.20M |
| EBIT | -$182.30M |
| Net Income | -$204.15M |
| Revenue Q/Q | 16.98% |
| Revenue Y/Y | 19.93% |
| P/E ratio | -52.23 |
|---|---|
| EV/Sales | 5.05 |
| EV/EBITDA | 241.60 |
| EV/EBIT | -69.18 |
| P/S ratio | 4.27 |
| P/B ratio | 3.39 |
| Book/Share | 17.33 |
| Cash/Share | 3.34 |
| EPS | -$1.13 |
|---|---|
| ROA | -3.20% |
| ROE | -6.60% |
| Debt/Equity | 1.06 |
|---|---|
| Net debt/EBITDA | 52.12 |
| Current ratio | 2.32 |
| Quick ratio | 2.07 |